Clinical Trials
2 trialsNCT00310128 2016-02-03
Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma
AIDS Malignancy Consortium
Phase 2 Withdrawn
NCT00177554 2008-05-29
Phase II Trial of CHOP-R Followed by Zevalin and Rituxan in Follicular Lymphoma
University of Pittsburgh
Phase 2 Completed